LE WE PMID CA
Angiogenesis3854Angiogenese

ACVRLK1

AGGF1 VG5Q

ALK1

Angiogenesis

Angiopoietin2

Antiinflammatory compounds

Antineoplastic agents (Tumor vascular disrupting agents)

Apoptosis

Arthritis (rheumatoid)

ASA404

Asymmetric dimethylarginine

Atherosclerosis (BASKET)

Autonomous nervous system (BASKET)

Basophils

BDNF

bFGF

Biomarker (BASKET)

Blood vessels (Malformation)

Blood vessels (Pericytes)

Bone (Neoplasia Ewing s sarcoma)

Calsenilin KCNIP3 CSEN DREAM

CD105

CD13 aminopeptidase N

Cell migration

Cell Secretion (Exosomes)

Circulation (Anatomy)

Circulation (Development)

Cloche

CNS (Development)

CNS (Neoplasia Glioma)

CNS (Neoplasia)

COL3A1

DLL4

Double minute2

EGFL7

Endoglin

Endostatin

Endothelial cell (Progenitor)

Endothelium

ENG

Ephrin

Erucin

Eye (Development)

Eye (Retina BASKET)

Factor XIII (Coagulation)

FGF2

Filopodia

FOXC2

Frizzled4

Galectin1

Glomulin

Heart (Coronary heart disease BASKET)

Hedgehog

Hemopoiesis (embryonal)

HGF

Histochemistry

Histone deacetylase

HSP90

Hydrogensulfide

Indinavir

Interleukin24 MDA7

JAM1

JNK

Kidney (Fibrosis)

Klippel Trenaunay syndrome

KRIT1

LRP5 LDL Receptor Related Protein5 Arrow

Lycat

Lymphatics (Development)

Lysyl oxidase

Macrophages

MADH4

Mast cells

Matrix metalloproteinase

MEF2c

MGC4607

MiRNA 126

Morphogenesis (Development)

MRT (Instrumentation)

NADPH oxidase

Nanomedicine

NDP

NEMO

Neoplasia (Electrochemotherapy)

Neoplasia (Invasion and metastasis)

Neoplasia (Tumor biology and immunology)

Nestin

Netrin

Neuroendocrine system (Neoplasia)

NFATc1

NGR pharmacophore

Norrin

Notch

NOTCH3

ORAI1 CRACM1

PCD (Multiple myeloma and other plasma cell dyscrasias)

PDCD10

PTEN MMAC1 TEP1

Pulmonary emphysema

Pulmonary hypertension

Radiation therapy

RASA1

Receptor (Interleukin22)

Receptor (TGF beta family)

Regeneration of tissues and other biologic structures

RNA (MicroRNA)

Sarcoma

Semaphorin

Skin (Neoplasia Melanoma)

SOX18

Sphingosine1 phosphate

SRF

Statin

Stem cell (Adult)

Structure det. tissue level to single molecule localization

Structure determination at molecular level and finer

SU11248

TGF beta

Thrombospondin

Thymidine phosphorylase

Thymosin beta4

Tie2

TIMP2

TIMP3

Transporter (Sodium and proton)

TRPV4

Tspan12

UNC5

VEGF

VEGFR3

Wnt beta Catenin TCF

Wound healing

ZD6126

ZD6474

Zidovudine

2004  
1
Therapeutic angiogenesis using vascular endothelial growth factor.
[15213090] Asian Cardiovasc Thorac Ann 12(2): 173-81 (2004)
2008  
2
Vascular repair by endothelial progenitor cells.
[18349136] Cardiovasc Res 78(3): 413-21 (2008)
2008  
3
Mechanisms of angiogenesis and remodelling of the microvasculature.
[18339645] Cardiovasc Res 78(2): 201-2 (2008)
2008  
4
Neural guidance molecules, tip cells, and mechanical factors in vascular development.
[18316324] Cardiovasc Res 78(2): 232-41 (2008)
2008  
5
Besides adhesion: new perspectives of integrin functions in angiogenesis.
[18285512] Cardiovasc Res 78(2): 213-22 (2008)
2008  
6
Post-ischaemic neovascularization and inflammation.
[18252762] Cardiovasc Res 78(2): 242-9 (2008)
2008  
7
Understanding the immunoangiostatic CXC chemokine network.
[18252760] Cardiovasc Res 78(2): 250-6 (2008)
2008  
8
Cardiovascular risk factors impair native collateral development and may impair efficacy of therapeutic interventions.
[18178573] Cardiovasc Res 78(2): 257-64 (2008)
2008  
9
Endothelial sprouting and angiogenesis: matrix metalloproteinases in the lead.
[18079100] Cardiovasc Res 78(2): 203-12 (2008)
2008  
10
Non-canonical fibroblast growth factor signalling in angiogenesis.
[18056763] Cardiovasc Res 78(2): 223-31 (2008)
2005  
11
Role of neural guidance signals in blood vessel navigation.
[15664389] Cardiovasc Res 65(3): 629-38 (2005)
2005  
12
Control of arterial branching morphogenesis in embryogenesis: go with the flow.
[15664388] Cardiovasc Res 65(3): 619-28 (2005)
2003  
13
Building better blood vessels: new insight on the molecular control of arteriogenesis.
[14499852] Cardiovasc Res 59(3): 532-3 (2003)
2003  
14
De novo vasculogenesis in the heart.
[12757872] Cardiovasc Res 58(2): 378-89 (2003)
2001  
15
Platelet-released phospholipids link haemostasis and angiogenesis.
[11166272] Cardiovasc Res 49(3): 588-99 (2001)
2001  
16
Stimulation of arteriogenesis; a new concept for the treatment of arterial occlusive disease.
[11166267] Cardiovasc Res 49(3): 543-53 (2001)
2001  
17
Therapeutic interventions for enhancing collateral development by administration of growth factors: basic principles, early results and potential hazards.
[11166266] Cardiovasc Res 49(3): 532-42 (2001)
2001  
18
Molecular mechanisms of blood vessel growth.
[11166264] Cardiovasc Res 49(3): 507-21 (2001)
1998  
19
Mouse models of angiogenesis, arterial stenosis, atherosclerosis and hemostasis.
[9764187] Cardiovasc Res 39(1): 8-33 (1998)
1996  
20
Early embryonic vascular development.
[8681344] Cardiovasc Res 31 Spec No(-): E34-45 (1996)
2003  
21
Designer blood vessels and therapeutic revascularization.
[14534146] Br J Pharmacol 140(4): 627-36 (2003)
2003  
22
Myoblast-mediated gene transfer for therapeutic angiogenesis and arteriogenesis.
[14534145] Br J Pharmacol 140(4): 620-6 (2003)
2003  
23
Emerging concept in angiogenesis: specification of arterial and venous endothelial cells.
[14534144] Br J Pharmacol 140(4): 611-3 (2003)
2003  
24
Fishing for novel angiogenic therapies.
[14534143] Br J Pharmacol 140(4): 585-94 (2003)
2007  
25
Nonclassic endogenous novel [corrected] regulators of angiogenesis.
[17540906] Pharmacol Rev 59(2): 185-205 (2007)
2004  
26
Vascular endothelial growth factor and angiogenesis.
[15602010] Pharmacol Rev 56(4): 549-80 (2004)
2000  
27
Angiogenesis: potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation.
[10835101] Pharmacol Rev 52(2): 237-68 (2000)
2006  
28
The duality of angiogenesis: implications for therapy of human disease.
[16983325] J Invest Dermatol 126(10): 2160-6 (2006)
2008  
29
Insights into mechanisms behind arteriogenesis: what does the future hold?
[18678607] J Leukoc Biol 84(6): 1379-91 (2008)
2001  
30
Microenvironmental influence on macrophage regulation of angiogenesis in wounds and malignant tumors.
[11590184] J Leukoc Biol 70(4): 478-90 (2001)
1994  
31
2004  
32
Angiostatin and anti-angiogenic therapy in human disease.
[14749498] Recent Prog Horm Res 59(-): 73-104 (2004)
2004  
33
Functional significance of Tie2 signaling in the adult vasculature.
[14749497] Recent Prog Horm Res 59(-): 51-71 (2004)
2010  
34
Stimulation of functional vessel growth by gene therapy.
[20473388] Integr Biol (Camb) 2(2-3): 102-12 (2010)
2009  
35
Novel insights into the differential functions of Notch ligands in vascular formation.
[20016694] J Angiogenes Res 1(-): 8 (2009)
2003  
36
Reciprocal regulation between nitric oxide and vascular endothelial growth factor in angiogenesis.
[12673346] Acta Biochim Pol 50(1): 49-59 (2003)
2003  
37
The enigmatic role of angiopoietin-1 in tumor angiogenesis.
[14672554] Cell Res 13(5): 309-17 (2003)
2009  
38
Influence of the oxygen microenvironment on the proangiogenic potential of human endothelial colony forming cells.
[19544080] Angiogenesis 12(4): 303-11 (2009)
2009  
39
Single and combined effects of alphavbeta3- and alpha5beta1-integrins on capillary tube formation in a human fibrinous matrix.
[19449108] Angiogenesis 12(3): 275-85 (2009)
2009  
40
Cooperation between integrin alphavbeta3 and VEGFR2 in angiogenesis.
[19267251] Angiogenesis 12(2): 177-85 (2009)
2009  
41
Role of endothelial progenitors and other bone marrow-derived cells in the development of the tumor vasculature.
[19221886] Angiogenesis 12(2): 159-64 (2009)
2009  
42
Fibronectins in vascular morphogenesis.
[19219555] Angiogenesis 12(2): 165-75 (2009)
2008  
43
Lysophosphatidic acid (LPA) and angiogenesis.
[18504643] Angiogenesis 11(3): 301-10 (2008)
2008  
44
Angiogenic-regulatory network revealed by molecular profiling heart tissue following Akt1 induction in endothelial cells.
[18491207] Angiogenesis 11(3): 289-99 (2008)
2008  
45
Akt1 is necessary for the vascular maturation and angiogenesis during cutaneous wound healing.
[18415691] Angiogenesis 11(3): 277-88 (2008)
2008  
46
Vascular permeability, vascular hyperpermeability and angiogenesis.
[18293091] Angiogenesis 11(2): 109-19 (2008)
2004  
47
Pathological angiogenesis is reduced by targeting pericytes via the NG2 proteoglycan.
[15609081] Angiogenesis 7(3): 269-76 (2004)
2003  
48
Early contribution of pericytes to angiogenic sprouting and tube formation.
[15041800] Angiogenesis 6(3): 241-9 (2003)
2009  
49
The role of the Angiopoietins in vascular morphogenesis.
[19449109] Angiogenesis 12(2): 125-37 (2009)
2009  
50
Wnt2 acts as an angiogenic growth factor for non-sinusoidal endothelial cells and inhibits expression of stanniocalcin-1.
[19444628] Angiogenesis 12(3): 251-65 (2009)
2009  
51
The endothelial cell tube formation assay on basement membrane turns 20: state of the science and the art.
[19399631] Angiogenesis 12(3): 267-74 (2009)
2009  
52
Semaphorins and tumor angiogenesis.
[19266292] Angiogenesis 12(2): 187-93 (2009)
2009  
53
Chloride intracellular channel 4 is involved in endothelial proliferation and morphogenesis in vitro.
[19247789] Angiogenesis 12(3): 209-20 (2009)
2009  
54
A comparative study on the anti-angiogenic effects of DNA-damaging and cytoskeletal-disrupting agents.
[19214765] Angiogenesis 12(1): 81-90 (2009)
2009  
55
Molecular differentiation and specialization of vascular beds.
[19212819] Angiogenesis 12(2): 139-47 (2009)
2009  
56
Intussusceptive angiogenesis and its role in vascular morphogenesis, patterning, and remodeling.
[19194777] Angiogenesis 12(2): 113-23 (2009)
2009  
57
Intermittent hypoxia is an angiogenic inducer for endothelial cells: role of HIF-1.
[19184477] Angiogenesis 12(1): 47-67 (2009)
2009  
58
Morphological and molecular aspects of physiological vascular morphogenesis.
[19130273] Angiogenesis 12(2): 101-11 (2009)
2009  
59
Osteoprotegerin and RANKL differentially regulate angiogenesis and endothelial cell function.
[19105036] Angiogenesis 12(1): 35-46 (2009)
2008  
60
Circulating and imaging markers for angiogenesis.
[18925424] Angiogenesis 11(4): 321-35 (2008)
2008  
61
PPAR gamma ligands, rosiglitazone and pioglitazone, inhibit bFGF- and VEGF-mediated angiogenesis.
[18810647] Angiogenesis 11(4): 361-7 (2008)
2008  
62
A role for planar cell polarity signaling in angiogenesis.
[18798004] Angiogenesis 11(4): 347-60 (2008)
2008  
63
The chick embryo chorioallantoic membrane as a model to study tumor metastasis.
[18780151] Angiogenesis 11(4): 311-9 (2008)
2008  
64
Farnesyltransferase inhibitors target multiple endothelial cell functions in angiogenesis.
[18758974] Angiogenesis 11(4): 337-46 (2008)
2008  
65
Mechanisms of adaptive angiogenesis to tissue hypoxia.
[18327686] Angiogenesis 11(2): 121-40 (2008)
2008  
66
Hedgehog signalling in vascular development.
[18301996] Angiogenesis 11(1): 71-7 (2008)
2008  
67
Neuropilin structure governs VEGF and semaphorin binding and regulates angiogenesis.
[18283547] Angiogenesis 11(1): 31-9 (2008)
2008  
68
Endoglin in angiogenesis and vascular diseases.
[18283546] Angiogenesis 11(1): 79-89 (2008)
2008  
69
Netrins and UNC5 receptors in angiogenesis.
[18266062] Angiogenesis 11(1): 23-9 (2008)
2008  
70
Slits and Roundabouts in cancer, tumour angiogenesis and endothelial cell migration.
[18264786] Angiogenesis 11(1): 13-21 (2008)
2008  
71
Regulation of angiogenesis by homotypic and heterotypic notch signalling in endothelial cells and pericytes: from basic research to potential therapies.
[18256896] Angiogenesis 11(1): 41-51 (2008)
2008  
72
Wnt/Frizzled signaling in angiogenesis.
[18253847] Angiogenesis 11(1): 63-9 (2008)
2008  
73
Differential gene expression analysis of tubule forming and non-tubule forming endothelial cells: CDC42GAP as a counter-regulator in tubule formation.
[18060510] Angiogenesis 11(2): 153-67 (2008)
2007  
74
Aortic rings stimulate inflammatory angiogenesis in a subcutaneous implant in vivo model.
[17786574] Angiogenesis 10(4): 287-95 (2007)
2007  
75
Angiogenic response of endothelial cells seeded dispersed versus on beads in fibrin gels.
[17721825] Angiogenesis 10(4): 269-77 (2007)
2007  
76
Thymosin beta4 and angiogenesis: modes of action and therapeutic potential.
[17632766] Angiogenesis 10(4): 229-41 (2007)
2007  
77
T-cadherin suppresses angiogenesis in vivo by inhibiting migration of endothelial cells.
[17486418] Angiogenesis 10(3): 183-95 (2007)
2007  
78
Angiogenesis and chronic inflammation: cause or consequence?
[17457680] Angiogenesis 10(3): 149-66 (2007)
2007  
79
Combination therapy for the treatment of ocular neovascularization.
[17372853] Angiogenesis 10(2): 141-8 (2007)
2007  
80
Progenitor cells and retinal angiogenesis.
[17372851] Angiogenesis 10(2): 89-101 (2007)
2007  
81
Development of the retinal vasculature.
[17322966] Angiogenesis 10(2): 77-88 (2007)
2007  
82
Regulation of endothelial cell migration by amphiphiles - are changes in cell membrane physical properties involved?
[17265099] Angiogenesis 10(1): 13-22 (2007)
2007  
83
An intimate interplay between precocious, migrating pericytes and endothelial cells governs human fetal brain angiogenesis.
[17225955] Angiogenesis 10(1): 35-45 (2007)
2007  
84
Vascular development is disrupted by endothelial cell-specific expression of the anti-apoptotic protein Bcl-2.
[17149535] Angiogenesis 10(1): 55-68 (2007)
2007  
85
CCN family proteins and angiogenesis: from embryo to adulthood.
[17149534] Angiogenesis 10(1): 1-11 (2007)
2006  
86
Inhibition of laminin-8 in vivo using a novel poly(malic acid)-based carrier reduces glioma angiogenesis.
[17109197] Angiogenesis 9(4): 183-91 (2006)
2006  
87
Immunohistochemical measurement of endothelial cell apoptosis and proliferation in formalin-fixed, paraffin-embedded human cancer tissue.
[17109196] Angiogenesis 9(4): 193-200 (2006)
2006  
88
Vascular endothelial growth factor receptor-1 (VEGFR-1/Flt-1): a dual regulator for angiogenesis.
[17109193] Angiogenesis 9(4): 225-30; discussion 231 (2006)
2006  
89
Unique vascular phenotypes following over-expression of individual VEGFA isoforms from the developing lens.
[17109192] Angiogenesis 9(4): 209-24 (2006)
2006  
90
Fine-tuning of a three-dimensional microcarrier-based angiogenesis assay for the analysis of endothelial-mesenchymal cell co-cultures in fibrin and collagen gels.
[17051343] Angiogenesis 9(3): 111-25 (2006)
2006  
91
Angiogenesis - understanding the mathematical challenge.
[17051342] Angiogenesis 9(3): 127-38 (2006)
2006  
92
Human melanoma cells transplanted into zebrafish proliferate, migrate, produce melanin, form masses and stimulate angiogenesis in zebrafish.
[17051341] Angiogenesis 9(3): 139-51 (2006)
2005  
93
Three-dimensional reconstruction of tumor microvasculature: simultaneous visualization of multiple components in paraffin-embedded tissue.
[16328157] Angiogenesis 8(4): 297-305 (2005)
2005  
94
Angiogenesis in the human heart: gene and cell therapy.
[16308736] Angiogenesis 8(3): 241-51 (2005)
2005  
95
Angiogenesis in ischaemic and hypertrophic hearts induced by long-term bradycardia.
[16308735] Angiogenesis 8(3): 253-62 (2005)
2005  
96
EDB fibronectin and angiogenesis -- a novel mechanistic pathway.
[16308732] Angiogenesis 8(3): 183-96 (2005)
2005  
97
Vascular morphogenesis in the primate ovary.
[16240058] Angiogenesis 8(2): 101-16 (2005)
2005  
98
Angiogenesis in normal and neoplastic ovaries.
[16211363] Angiogenesis 8(2): 169-82 (2005)
2005  
99
Lymphangiogenesis in human gynaecological cancers.
[16211357] Angiogenesis 8(2): 137-45 (2005)
2004  
100
The receptor tyrosine kinase inhibitor SU11248 impedes endothelial cell migration, tubule formation, and blood vessel formation in vivo, but has little effect on existing tumor vessels.
[15609077] Angiogenesis 7(3): 225-33 (2004)
2004  
101
In vivo videomicroscopy reveals differential effects of the vascular-targeting agent ZD6126 and the anti-angiogenic agent ZD6474 on vascular function in a liver metastasis model.
[15516836] Angiogenesis 7(2): 157-64 (2004)
2004  
102
Eph receptor tyrosine kinases in angiogenesis: from development to disease.
[15302992] Angiogenesis 7(1): 17-28 (2004)
2004  
103
Quantitative angiogenesis assays in vivo--a review.
[15302991] Angiogenesis 7(1): 1-16 (2004)
2003  
104
A modified chorioallantoic membrane assay allows for specific detection of endothelial apoptosis induced by antiangiogenic substances.
[15041801] Angiogenesis 6(3): 251-4 (2003)
2003  
105
Discovery and development of anti-angiogenic peptides: A structural link.
[14739615] Angiogenesis 6(2): 83-91 (2003)
2003  
106
Angiogenesis mediated by metabolites is dependent on vascular endothelial growth factor (VEGF).
[14517407] Angiogenesis 6(1): 73-7 (2003)
2002  
107
Anti-angiogenic therapy: rationale, challenges and clinical studies.
[12906317] Angiogenesis 5(4): 237-56 (2002)
2002  
108
Comparative study of isoflavone, quinoxaline and oxindole families of anti-angiogenic agents.
[12549859] Angiogenesis 5(1-2): 45-51 (2002)
2001  
109
Endostatin inhibits angiogenesis by stabilization of newly formed endothelial tubes.
[11911017] Angiogenesis 4(3): 193-206 (2001)
2001  
110
A study of metabolites as intermediate effectors in angiogenesis.
[11824381] Angiogenesis 4(1): 71-7 (2001)
2001  
111
Improved quantification of angiogenesis in the rat aortic ring assay.
[11806245] Angiogenesis 4(2): 133-42 (2001)
2001  
112
Comparison of three in vitro human 'angiogenesis' assays with capillaries formed in vivo.
[11806243] Angiogenesis 4(2): 113-21 (2001)
1999  
113
Peroxovanadium compounds as inhibitors of angiogenesis.
[14517416] Angiogenesis 3(4): 361-9 (1999)
1999  
114
Zebrafish angiogenesis: a new model for drug screening.
[14517415] Angiogenesis 3(4): 353-9 (1999)
1999  
115
An in vitro model of angiogenesis: basic features.
[14517413] Angiogenesis 3(4): 335-44 (1999)
1999  
116
A novel method of visualizing vessels in human tumor biopsies.
[14517408] Angiogenesis 3(4): 291-3 (1999)
1998  
117
Influence of fibrin structure on the formation and maintenance of capillary-like tubules by human microvascular endothelial cells.
[14517471] Angiogenesis 2(2): 153-65 (1998)
1999  
118
Regulation of angiogenesis and endothelial cell motility by matrix-bound fibroblasts.
[14517446] Angiogenesis 3(1): 69-76 (1999)
1999  
119
Angiogenesis and ophthalmic disease.
[14517440] Angiogenesis 3(1): 9-14 (1999)
1999  
120
Role of endothelial cell survival and death signals in angiogenesis.
[14517428] Angiogenesis 3(2): 101-16 (1999)
1998  
121
Tubular morphogenesis by genotoxic therapeutic agents that induce NF-kappaB activation in human vascular endothelial cells.
[14517454] Angiogenesis 2(4): 345-56 (1998)
1998  
122
The formation of tubular structures by endothelial cells is under the control of fibrinolysis and mechanical factors.
[14517453] Angiogenesis 2(4): 331-44 (1998)
2001  
123
2007  
124
Signaling mechanisms of endogenous angiogenesis inhibitors derived from type IV collagen.
[19936090] Gene Regul Syst Bio 1(-): 217-26 (2007)
2008  
125
The hepatocyte growth factor/c-Met signaling pathway as a therapeutic target to inhibit angiogenesis.
[19123972] BMB Rep 41(12): 833-9 (2008)
2008  
126
Vascular endothelial growth factor-dependent and -independent regulation of angiogenesis.
[18452647] BMB Rep 41(4): 278-86 (2008)
2007  
127
Optimized fibrin gel bead assay for the study of angiogenesis.
[18978935] J Vis Exp -(3): 186 (2007)
1987  
128
Angiostatic steroids. Method of discovery and mechanism of action.
[2443088] Ann Surg 206(3): 374-83 (1987)
2001  
129
The hemostatic system and angiogenesis in malignancy.
[11687948] Neoplasia 3(5): 371-84 (2001)
2006  
130
How molecular imaging is speeding up antiangiogenic drug development.
[17121909] Mol Cancer Ther 5(11): 2624-33 (2006)
2008  
131
VEGF and Delta-Notch: interacting signalling pathways in tumour angiogenesis.
[18827808] Br J Cancer 99(8): 1204-9 (2008)
2007  
132
Vascular disrupting agents in clinical development.
[17375046] Br J Cancer 96(8): 1159-65 (2007)
2006  
133
Adrenomedullin and tumour angiogenesis.
[16251875] Br J Cancer 94(1): 1-7 (2006)
2005  
134
The clinical potential of antiangiogenic fragments of extracellular matrix proteins.
[16234821] Br J Cancer 93(9): 967-72 (2005)
2003  
135
New molecular pathways in angiogenesis.
[12865906] Br J Cancer 89(2): 228-31 (2003)
1995  
136
Tumour vasculature--a potential therapeutic target.
[7543770] Br J Cancer 72(2): 257-67 (1995)
2005  
137
The role of dendritic cell precursors in tumour vasculogenesis.
[15785750] Br J Cancer 92(7): 1182-7 (2005)
2000  
138
Progress in antiangiogenic gene therapy of cancer.
[11002212] Cancer 89(6): 1181-94 (2000)
2007  
139
Hypoxia inducible factor-1 independent pathways in tumor angiogenesis.
[17908955] Clin Cancer Res 13(19): 5670-4 (2007)
2007  
140
Molecular pathways for cancer angioprevention.
[17671111] Clin Cancer Res 13(15 Pt 1): 4320-5 (2007)
1996  
141
What is the role of thymidine phosphorylase in tumor angiogenesis.
[8757181] J Natl Cancer Inst 88(16): 1091-2 (1996)
2008  
142
Molecular links between tumor angiogenesis and inflammation: inflammatory stimuli of macrophages and cancer cells as targets for therapeutic strategy.
[18754859] Cancer Sci 99(8): 1501-6 (2008)
2008  
143
Understanding tumor endothelial cell abnormalities to develop ideal anti-angiogenic therapies.
[18167133] Cancer Sci 99(3): 459-66 (2008)
2006  
144
Role of hematopoietic lineage cells as accessory components in blood vessel formation.
[16827795] Cancer Sci 97(7): 568-74 (2006)
2004  
145
The role of thymidine phosphorylase, an angiogenic enzyme, in tumor progression.
[15546501] Cancer Sci 95(11): 851-7 (2004)
2005  
146
Tumor inflammatory angiogenesis and its chemoprevention.
[16322203] Cancer Res 65(23): 10637-41 (2005)
2005  
147
Endogenous inhibitors of angiogenesis.
[15899784] Cancer Res 65(10): 3967-79 (2005)
2000  
148
Vascular endothelial growth factor receptors in the regulation of angiogenesis and lymphangiogenesis.
[11114740] Oncogene 19(49): 5598-605 (2000)
1999  
149
Growth factor signaling pathways in vascular development.
[10630644] Oncogene 18(55): 7917-32 (1999)
1999  
150
New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF.
[10498889] Oncogene 18(38): 5356-62 (1999)
2004  
151
Tumor angiogenesis in mice and men.
[15153806] Cancer Biol Ther 3(6): 498-500 (2004)
2003  
152
Tissue factor signal transduction in angiogenesis.
[12807741] Carcinogenesis 24(6): 1009-13 (2003)
2000  
153
Tumor angiogenesis: past, present and the near future.
[10688871] Carcinogenesis 21(3): 505-15 (2000)
1998  
154
Current concepts of tumor-induced angiogenesis.
[9555124] Pathol Oncol Res 4(1): 62-75 (1998)
2008  
155
A dialogue between the hypoxia-inducible factor and the tumor microenvironment.
[19308685] Cancer Microenviron 1(1): 53-68 (2008)
2010  
156
Angiogenesis: an update and potential drug approaches (review).
[19956828] Int J Oncol 36(1): 5-18 (2010)
2009  
157
Development of targeted angiogenic medicine.
[18983480] J Thromb Haemost 7(1): 21-33 (2009)
2009  
158
Emerging mechanisms of vascular stabilization.
[19630769] J Thromb Haemost 7 Suppl 1(-): 57-60 (2009)
2006  
159
Factor XIII (FXIII) and angiogenesis.
[16129024] J Thromb Haemost 4(1): 19-25 (2006)
2005  
160
1995  
161
The pathophysiology of angiogenesis.
[8785263] Crit Rev Oral Biol Med 6(3): 230-47 (1995)
2007  
162
Imaging of angiogenesis: clinical techniques and novel imaging methods.
[17179341] AJR Am J Roentgenol 188(1): 11-23 (2007)
1983  
163
Caldwell Lecture. The collateral circulation: response to ischemia.
[6344594] AJR Am J Roentgenol 140(6): 1051-63 (1983)
2008  
164
Advances in anatomic, functional, and molecular imaging of angiogenesis.
[18375921] J Nucl Med 49(4): 511-4 (2008)
2007  
165
Non-receptor protein-tyrosine kinases as molecular targets for antiangiogenic therapy (Review).
[17549397] Int J Mol Med 20(1): 113-21 (2007)
2003  
166
Antivascular cancer treatments: imaging biomarkers in pharmaceutical drug development.
[15456717] Br J Radiol 76 Spec No 1(-): S83-6 (2003)
2003  
167
Angiogenesis imaging in man: a personal view from the pharmaceutical industry.
[15456716] Br J Radiol 76 Spec No 1(-): S81-2 (2003)
2003  
168
MRI for assessing antivascular cancer treatments.
[15456715] Br J Radiol 76 Spec No 1(-): S60-80 (2003)
2003  
169
Positron emission tomographic imaging of angiogenesis and vascular function.
[15456714] Br J Radiol 76 Spec No 1(-): S50-9 (2003)
2003  
170
2003  
171
Perfusion CT for the assessment of tumour vascularity: which protocol?
[15456712] Br J Radiol 76 Spec No 1(-): S36-42 (2003)
2003  
172
Measuring tumour vascular response to antivascular and antiangiogenic drugs.
[15456711] Br J Radiol 76 Spec No 1(-): S23-35 (2003)
2003  
173
Microenvironmental and cellular consequences of altered blood flow in tumours.
[15456710] Br J Radiol 76 Spec No 1(-): S11-22 (2003)
2003  
174
Translating angiogenesis research into the clinic: the challenges ahead.
[15456709] Br J Radiol 76 Spec No 1(-): S3-10 (2003)
2003  
175
Angiogenesis imaging in the post-genomic era.
[15456708] Br J Radiol 76 Spec No 1(-): S1-2 (2003)
2008  
176
Application of angiogenesis to clinical dermatology.
[19256307] Adv Dermatol 24(-): 89-103 (2008)
2005  
177
How Avastin potentiates chemotherapeutic drugs: action and reaction in antiangiogenic therapy.
[16322683] Cancer Biol Ther 4(12): 1307-10 (2005)
2006  
178
Lysyl oxidase (LOX) and hypoxia-induced metastases.
[16969095] Cancer Biol Ther 5(8): 909-11 (2006)
2009  
179
Imaging of tumor angiogenesis: functional or targeted?
[19620425] AJR Am J Roentgenol 193(2): 304-13 (2009)
2008  
180
Imaging angiogenesis and the microenvironment.
[18834413] APMIS 116(7-8): 695-715 (2008)
2009  
181
The definition of EPCs and other bone marrow cells contributing to neoangiogenesis and tumor growth: is there common ground for understanding the roles of numerous marrow-derived cells in the neoangiogenic process?
[19393290] Biochim Biophys Acta 1796(1): 50-4 (2009)
2006  
182
New insights regarding vessel regression.
[16969103] Cell Cycle 5(18): 2057-9 (2006)
2010  
183
Netrin-1 role in angiogenesis: to be or not to be a pro-angiogenic factor?
[20372055] Cell Cycle 9(8): 1466-71 (2010)
2011  
184
Nestin in gastrointestinal and other cancers: effects on cells and tumor angiogenesis.
[21274370] World J Gastroenterol 17(4): 409-18 (2011)
2011  
185
Imaging techniques used for the real-time assessment of angiogenesis in digestive cancers.
[21218077] World J Gastroenterol 17(1): 7-8 (2011)
2007  
186
Renal side effects of anti-VEGF therapy in man: a new test system.
[17616538] Nephrol Dial Transplant 22(10): 2778-80 (2007)
2008  
187
Therapeutic angiogenesis for critical limb ischemia: microvascular therapies coming of age.
[18591450] Circulation 118(1): 9-16 (2008)
2007  
188
Angiogenesis in chronic lung disease.
[17356107] Chest 131(3): 874-9 (2007)
2008  
189
Colorectal tumor vascularity: quantitative assessment with multidetector CT--do tumor perfusion measurements reflect angiogenesis?
[18812560] Radiology 249(2): 510-7 (2008)
2010  
190
A miR-thless perspective: how asymmetric dimethylarginine impairs the functions of angiogenic progenitor cells.
[20616336] Circ Res 107(1): 12-4 (2010)
2010  
191
The role of wnt signaling in physiological and pathological angiogenesis.
[20947863] Circ Res 107(8): 943-52 (2010)
2007  
192
New targeted angiogenic strategy: bursting bubbles.
[17673683] Circ Res 101(3): 232-3 (2007)
2007  
193
A novel application for murine double minute 2 antagonists: the p53 tumor suppressor network also controls angiogenesis.
[17204660] Circ Res 100(1): 13-4 (2007)
2008  
194
Lycat and cloche at the switch between blood vessel growth and differentiation?
[18467639] Circ Res 102(9): 1005-7 (2008)
2011  
195
Quantifying tumor vascular heterogeneity with dynamic contrast-enhanced magnetic resonance imaging: a review.
[21541193] J Biomed Biotechnol 2011(-): 732848 (2011)
2010  
196
ADAM-mediated shedding, a new flavor in angiogenesis regulation.
[20962296] Arterioscler Thromb Vasc Biol 30(11): 2087-8 (2010)
2003  
197
JAM-1 regulation of endothelial cell migration: implications for angiogenesis.
[14672878] Arterioscler Thromb Vasc Biol 23(12): 2119-20 (2003)
2009  
198
The opening act: vasculogenesis and the origins of circulation.
[19008532] Arterioscler Thromb Vasc Biol 29(5): 623-9 (2009)
2009  
199
Mechanisms of vessel branching: filopodia on endothelial tip cells lead the way.
[19265031] Arterioscler Thromb Vasc Biol 29(5): 639-49 (2009)
2009  
200
Kallikrein-kinin system in neovascularization.
[19369653] Arterioscler Thromb Vasc Biol 29(5): 617-9 (2009)
2009  
201
Endothelial-mural cell signaling in vascular development and angiogenesis.
[19164813] Arterioscler Thromb Vasc Biol 29(5): 630-8 (2009)
2008  
202
Twin layers of lightning: a new role for the chaperone Hsp90 in angiogenesis.
[17975116] Arterioscler Thromb Vasc Biol 28(1): 6-7 (2008)
2007  
203
Something is rotten in the state of angiogenesis -- H2S as gaseous stimulator of angiogenesis.
[17706951] Cardiovasc Res 76(1): 1-2 (2007)
2011  
204
Toll-like receptors in angiogenesis.
[21516292] ScientificWorldJournal 11(-): 981-91 (2011)
2007  
205
Signal transduction induced in endothelial cells by growth factor receptors involved in angiogenesis.
[17334501] Thromb Haemost 97(3): 355-63 (2007)
2003  
206
Angiogenesis in endocrine tumors.
[14570746] Endocr Rev 24(5): 600-32 (2003)
1997  
207
Vascular development: cellular and molecular regulation.
[9141503] FASEB J 11(5): 365-73 (1997)
2007  
208
Building blood vessels--stem cell models in vascular biology.
[17535968] J Cell Biol 177(5): 751-5 (2007)
1999  
209
VEGF and vascular fusion: implications for normal and pathological vessels.
[10544208] J Histochem Cytochem 47(11): 1351-6 (1999)
2007  
210
Antiangiogenesis to treat cancer and intraocular neovascular disorders.
[17259997] Lab Invest 87(3): 227-30 (2007)
1986  
211
Endothelial cell-matrix interactions: in vitro models of angiogenesis.
[2416801] J Histochem Cytochem 34(1): 85-91 (1986)
2002  
212
Molecular basis of endothelial cell morphogenesis in three-dimensional extracellular matrices.
[12382323] Anat Rec 268(3): 252-75 (2002)
2001  
213
Chorioallantoic membrane capillary bed: a useful target for studying angiogenesis and anti-angiogenesis in vivo.
[11745087] Anat Rec 264(4): 317-24 (2001)
2000  
214
Angiogenesis: new insights and therapeutic potential.
[10867630] Anat Rec 261(3): 126-35 (2000)
2008  
215
Molecular and developmental biology of the hemangioblast.
[18429046] Dev Dyn 237(5): 1218-31 (2008)
2007  
216
Deciphering the signaling events that promote melanoma tumor cell vasculogenic mimicry and their link to embryonic vasculogenesis: role of the Eph receptors.
[17557303] Dev Dyn 236(12): 3283-96 (2007)
2004  
217
Intussusceptive angiogenesis: its emergence, its characteristics, and its significance.
[15376313] Dev Dyn 231(3): 474-88 (2004)
2001  
218
The role of FGF and VEGF in angioblast induction and migration during vascular development.
[11146503] Dev Dyn 220(1): 1-17 (2001)
1999  
219
What guides early embryonic blood vessel formation?
[10340752] Dev Dyn 215(1): 2-11 (1999)
2005  
220
Tracing the hemangioblast during embryogenesis: developmental relationships between endothelial and hematopoietic cells.
[15906241] Int J Dev Biol 49(2-3): 269-77 (2005)
2005  
221
Vascular development: from precursor cells to branched arterial and venous networks.
[15906240] Int J Dev Biol 49(2-3): 259-67 (2005)
2005  
222
Embryonic development of the human hematopoietic system.
[15906238] Int J Dev Biol 49(2-3): 243-50 (2005)
2004  
223
Development and pathology of the hyaloid, choroidal and retinal vasculature.
[15558494] Int J Dev Biol 48(8-9): 1045-58 (2004)
2004  
224
Parallels in invasion and angiogenesis provide pivotal points for therapeutic intervention.
[15349833] Int J Dev Biol 48(5-6): 583-98 (2004)
2002  
225
Pathways in blood and vessel development revealed through zebrafish genetics.
[12141436] Int J Dev Biol 46(4): 493-502 (2002)
1996  
226
The chick embryo chorioallantoic membrane as a model for in vivo research on angiogenesis.
[9032025] Int J Dev Biol 40(6): 1189-97 (1996)
2007  
227
Notch signaling in vascular development and physiology.
[17611219] Development 134(15): 2709-18 (2007)
2007  
228
Artery and vein formation: a tug of war between different forces.
[17906673] EMBO Rep 8(10): 920-4 (2007)
2005  
229
Neural guidance molecules regulate vascular remodeling and vessel navigation.
[15879551] Genes Dev 19(9): 1013-21 (2005)
1999  
230
Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development.
[10323857] Genes Dev 13(9): 1055-66 (1999)
2004  
231
The diversity of endothelial cells: a challenge for therapeutic angiogenesis.
[14759250] Genome Biol 5(2): 207 (2004)
2006  
232
Differential roles of vascular endothelial growth factor receptor-1 and receptor-2 in angiogenesis.
[17002866] J Biochem Mol Biol 39(5): 469-78 (2006)
2000  
233
The hemostatic system as a regulator of angiogenesis.
[10636838] J Biol Chem 275(3): 1521-4 (2000)
1992  
234
1998  
235
Angiogenesis and vasculogenesis in treatment of cardiovascular disease.
[9713822] Mol Med 4(7): 429-40 (1998)
2007  
236
Combinatorial protein therapy of angiogenic and arteriogenic factors remarkably improves collaterogenesis and cardiac function in pigs.
[17636133] Proc Natl Acad Sci U S A 104(29): 12140-5 (2007)
2002  
237
Won't you be my neighbor? Local induction of arteriogenesis.
[12176316] Cell 110(3): 289-92 (2002)
2002  
238
Walking the walk: migration and other common themes in blood and vascular development.
[11955426] Cell 108(6): 731-4 (2002)
1998  
239
Vasculogenesis, angiogenesis, and growth factors: ephrins enter the fray at the border.
[9630209] Cell 93(5): 661-4 (1998)
1996  
240
Blood vessel formation: what is its molecular basis?
[8980221] Cell 87(7): 1153-5 (1996)
1999  
241
2007  
242
Endothelium-microenvironment interactions in the developing embryo and in the adult.
[17276337] Dev Cell 12(2): 181-94 (2007)
2004  
243
Vascular morphogenesis and the formation of vascular networks.
[15068788] Dev Cell 6(4): 479-82 (2004)
2007  
244
Alternative vascularization mechanisms in cancer: Pathology and therapeutic implications.
[17200177] Am J Pathol 170(1): 1-15 (2007)
2001  
245
Glomeruloid microvascular proliferation orchestrated by VPF/VEGF: a new world of angiogenesis research.
[11238026] Am J Pathol 158(3): 789-96 (2001)
2000  
246
Vasculogenic mimicry: how convincing, how novel, and how significant?
[10666365] Am J Pathol 156(2): 383-8 (2000)
2000  
247
Vasculogenic mimicry and tumor angiogenesis.
[10666364] Am J Pathol 156(2): 361-81 (2000)
1999  
248
Tumor plasticity allows vasculogenic mimicry, a novel form of angiogenic switch. A rose by any other name?
[10487823] Am J Pathol 155(3): 675-9 (1999)
1998  
249
Ocular neovascularization: clarifying complex interactions.
[9736014] Am J Pathol 153(3): 665-70 (1998)
1997  
250
Vascular endothelial growth factor and ocular neovascularization.
[9212726] Am J Pathol 151(1): 13-23 (1997)
1995  
251
Between molecules and morphology. Extracellular matrix and creation of vascular form.
[7573362] Am J Pathol 147(4): 873-83 (1995)
2004  
252
Endothelial progenitor cells for postnatal vasculogenesis.
[15308462] Am J Physiol Cell Physiol 287(3): C572-9 (2004)
2002  
253
Mechanisms of normal and tumor-derived angiogenesis.
[11940508] Am J Physiol Cell Physiol 282(5): C947-70 (2002)
2008  
254
2008  
255
Regulation of vasculogenesis by platelet-mediated recruitment of bone marrow-derived cells.
[18096826] Arterioscler Thromb Vasc Biol 28(2): 217-22 (2008)
2007  
256
Developmental basis of vascular smooth muscle diversity.
[17379839] Arterioscler Thromb Vasc Biol 27(6): 1248-58 (2007)
2006  
257
Transcriptional regulators of angiogenesis.
[16778118] Arterioscler Thromb Vasc Biol 26(9): 1936-47 (2006)
2006  
258
Role of circulating vascular progenitors in angiogenesis, vascular healing, and pulmonary hypertension: lessons from animal models.
[16456096] Arterioscler Thromb Vasc Biol 26(5): 1008-14 (2006)
2006  
259
Pericellular proteases in angiogenesis and vasculogenesis.
[16469948] Arterioscler Thromb Vasc Biol 26(4): 716-28 (2006)
2005  
260
Mechanisms of endothelial differentiation in embryonic vasculogenesis.
[16123328] Arterioscler Thromb Vasc Biol 25(11): 2246-54 (2005)
2004  
261
Hereditary vascular anomalies: new insights into their pathogenesis.
[15231518] Arterioscler Thromb Vasc Biol 24(9): 1578-90 (2004)
2003  
262
Endothelial progenitor cells: mobilization, differentiation, and homing.
[12714439] Arterioscler Thromb Vasc Biol 23(7): 1185-9 (2003)
2002  
263
Re-endothelialization via bone marrow-derived progenitor cells: still another target of statins in vascular disease.
[12377721] Arterioscler Thromb Vasc Biol 22(10): 1509-11 (2002)
1997  
264
Manipulating angiogenesis. From basic science to the bedside.
[9108772] Arterioscler Thromb Vasc Biol 17(4): 605-19 (1997)
1998  
265
Review: angiogenesis: implications for rheumatoid arthritis.
[9627005] Arthritis Rheum 41(6): 951-62 (1998)
2005  
266
Unresolved questions, changing definitions, and novel paradigms for defining endothelial progenitor cells.
[15905185] Blood 106(5): 1525-31 (2005)
2006  
267
Akt1 in endothelial cell and angiogenesis.
[16552185] Cell Cycle 5(5): 512-8 (2006)
2004  
268
Red light, green light: signals that control endothelial cell proliferation during embryonic vascular development.
[15611620] Cell Cycle 3(12): 1506-11 (2004)
1997  
269
Receptor tyrosine kinase signaling in vascular development.
[8993829] Cell Growth Differ 8(1): 3-10 (1997)
2001  
270
Structure and function of VEGF/VEGF-receptor system involved in angiogenesis.
[11345501] Cell Struct Funct 26(1): 25-35 (2001)
2001  
271
Role of ETS family transcription factors in vascular development and angiogenesis.
[11345500] Cell Struct Funct 26(1): 19-24 (2001)
2000  
272
Collagen XVIII/endostatin structure and functional role in angiogenesis.
[10885579] Cell Struct Funct 25(2): 97-101 (2000)
2005  
273
Imaging of angiogenesis in inflamed airways and tumors: newly formed blood vessels are not alike and may be wildly abnormal: Parker B. Francis lecture.
[16373858] Chest 128(6 Suppl): 602S-608S (2005)
2005  
274
Phenotypic diversity of the lung vasculature in experimental models of metastases.
[16373855] Chest 128(6 Suppl): 596S-600S (2005)
1988  
275
Angiogenesis. State of the art.
[2449315] Chest 93(3 Suppl): 159S-166S (1988)
2008  
276
2008  
277
Crosstalk between vascular endothelial growth factor, notch, and transforming growth factor-beta in vascular morphogenesis.
[18369162] Circ Res 102(6): 637-52 (2008)
2007  
278
Endothelial precursor cell migration during vasculogenesis.
[17641236] Circ Res 101(2): 125-36 (2007)
2007  
279
Endothelial cell migration during angiogenesis.
[17395884] Circ Res 100(6): 782-94 (2007)
2005  
280
Endothelial extracellular matrix: biosynthesis, remodeling, and functions during vascular morphogenesis and neovessel stabilization.
[16306453] Circ Res 97(11): 1093-107 (2005)
2005  
281
Innate immunity and angiogenesis.
[15637304] Circ Res 96(1): 15-26 (2005)
2004  
282
Influence of mechanical, cellular, and molecular factors on collateral artery growth (arteriogenesis).
[15345667] Circ Res 95(5): 449-58 (2004)
2004  
283
Bone-marrow-derived cells for enhancing collateral development: mechanisms, animal data, and initial clinical experiences.
[15321945] Circ Res 95(4): 354-63 (2004)
2004  
284
Endothelial progenitor cells: characterization and role in vascular biology.
[15321944] Circ Res 95(4): 343-53 (2004)
2003  
285
Lessons from lymph: flow-guided vessel formation.
[12702638] Circ Res 92(7): 701-3 (2003)
2002  
286
Role of Akt signaling in vascular homeostasis and angiogenesis.
[12089061] Circ Res 90(12): 1243-50 (2002)
2001  
287
The putative convergent and divergent natures of angiogenesis and arteriogenesis.
[11679402] Circ Res 89(9): 747-9 (2001)
2001  
288
Tubes, branches, and pillars: the many ways of forming a new vasculature.
[11597985] Circ Res 89(8): 645-7 (2001)
2001  
289
Integrins in vascular development.
[11577021] Circ Res 89(7): 566-72 (2001)
2001  
290
Transcriptional regulation of vascular development.
[11532898] Circ Res 89(5): 380-8 (2001)
2001  
291
Drilling for oxygen: angiogenesis involves proteolysis of the extracellular matrix.
[11485968] Circ Res 89(3): 195-7 (2001)
2001  
292
Transcriptional regulation of vascular development.
[11157660] Circ Res 88(2): 127-8 (2001)
2001  
293
Control of vascular cell differentiation by homeiobox transcription factors.
[11139466] Circ Res 88(1): 7-8 (2001)
2000  
294
The role of homeobox genes in vascular remodeling and angiogenesis.
[11073881] Circ Res 87(10): 865-72 (2000)
2000  
295
Endothelial cell apoptosis in angiogenesis and vessel regression.
[10988233] Circ Res 87(6): 434-9 (2000)
2000  
296
Akt takes center stage in angiogenesis signaling.
[10625297] Circ Res 86(1): 4-5 (2000)
1999  
297
Vascular biology in genetically altered mice : smaller vessels, bigger insight.
[10590250] Circ Res 85(12): 1214-25 (1999)
1998  
298
Vascular endothelial growth factor and the angiopoietins: working together to build a better blood vessel.
[9710128] Circ Res 83(3): 342-3 (1998)
1996  
299
Molecular mechanisms of coronary collateral vessel growth.
[8888683] Circ Res 79(5): 911-9 (1996)
2003  
300
Clinician guide to angiogenesis.
[14638526] Circulation 108(21): 2613-8 (2003)
2003  
301
Angiogenesis: basic pathophysiology and implications for disease.
[12657217] Eur Heart J 24(7): 586-603 (2003)
2003  
302
Vascular morphogenesis: tales of two syndromes.
[12668602] Hum Mol Genet 12 Spec No 1(): R97-112 (2003)
1993  
303
Embryonic stem cell model systems for vascular morphogenesis and cardiac disorders.
[8406668] Hypertension 22(4): 618-29 (1993)
2000  
304
The basic helix-loop-helix transcription factor, dHAND, is required for vascular development.
[10675351] J Clin Invest 105(3): 261-70 (2000)
2009  
305
Mediators of ocular angiogenesis.
[20090210] J Genet 88(4): 495-515 (2009)
1999  
306
Role of vascular endothelial growth factor in the regulation of angiogenesis.
[10469350] Kidney Int 56(3): 794-814 (1999)
2005  
307
The role of pericytes in blood-vessel formation and maintenance.
[16212810] Neuro Oncol 7(4): 452-64 (2005)
2005  
308
The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis.
[15831231] Neuro Oncol 7(2): 122-33 (2005)
2005  
309
Endogenous inhibitors of angiogenesis in malignant gliomas: nature's antiangiogenic therapy.
[15831230] Neuro Oncol 7(2): 106-21 (2005)
2003  
310
Mechanism and its regulation of tumor-induced angiogenesis.
[12800214] World J Gastroenterol 9(6): 1144-55 (2003)
1997  
311
Regulation of vascular morphogenesis by the matricellular protein SPARC.
[9150448] Kidney Int 51(5): 1383-7 (1997)
2008  
312
2010  
313
The development of the vasculature and its extracellular matrix: a gradual process defined by sequential cellular and matrix remodeling events.
[20543090] Am J Physiol Heart Circ Physiol 299(2): H245-7 (2010)
2009  
314
Building a vessel wall with notch signaling.
[19246684] Circ Res 104(4): 419-21 (2009)
2011  
315
ALK1 as an emerging target for antiangiogenic therapy of cancer.
[21467543] Blood 117(26): 6999-7006 (2011)
2005  
316
2008  
317
The neovasculature homing motif NGR: more than meets the eye.
[18574027] Blood 112(7): 2628-35 (2008)
2010  
318
Some embryological aspects of cholinergic innervation in the cardiovascular system--a close association with the subintestinal circulatory channel.
[20351483] J Pharmacol Sci 112(4): 383-96 (2010)
2003  
319
Bone marrow angiogenesis in multiple myeloma: closing in on the loop.
[12604399] Haematologica 88(2): 122-4 (2003)
2005  
320
Biomedicine and diseases: the Klippel-Trenaunay syndrome, vascular anomalies and vascular morphogenesis.
[15905966] Cell Mol Life Sci 62(13): 1434-47 (2005)
2011  
321
The role of pericytes in angiogenesis.
[21710434] Int J Dev Biol 55(3): 261-8 (2011)
2011  
322
The interplay between macrophages and angiogenesis in development, tissue injury and regeneration.
[21732273] Int J Dev Biol 55(4-5): 495-503 (2011)
2010  
323
The Notch pathway in the developing hematopoietic system.
[20711994] Int J Dev Biol 54(6-7): 1175-88 (2010)
2010  
324
The seminal work of Werner Risau in the study of the development of the vascular system.
[20209430] Int J Dev Biol 54(4): 567-72 (2010)
2009  
325
Peptide hormone regulation of angiogenesis.
[19789380] Physiol Rev 89(4): 1177-215 (2009)
2003  
326
CD105 is important for angiogenesis: evidence and potential applications.
[12773481] FASEB J 17(9): 984-92 (2003)
2008  
327
2009  
328
Glioma angiogenesis: Towards novel RNA therapeutics.
[19262177] Cell Adh Migr 3(2): 230-5 (2009)
2009  
329
Cell lineages and early patterns of embryonic CNS vascularization.
[19270493] Cell Adh Migr 3(2): 205-10 (2009)
2009  
330
SRF in angiogenesis: branching the vascular system.
[19287204] Cell Adh Migr 3(3): 264-7 (2009)
2009  
331
AngiomiRs--key regulators of angiogenesis.
[19446450] Curr Opin Genet Dev 19(3): 205-11 (2009)
2010  
332
Disrupting established tumor blood vessels: an emerging therapeutic strategy for cancer.
[20166210] Cancer 116(8): 1859-71 (2010)
2007  
333
Tie2-expressing monocytes and tumor angiogenesis: regulation by hypoxia and angiopoietin-2.
[17875679] Cancer Res 67(18): 8429-32 (2007)
2009  
334
Catecholamines regulate tumor angiogenesis.
[19383906] Cancer Res 69(9): 3727-30 (2009)
2010  
335
Biomarkers of angiogenesis and their role in the development of VEGF inhibitors.
[20010945] Br J Cancer 102(1): 8-18 (2010)
2003  
336
Hydrogen ion dynamics and the Na+/H+ exchanger in cancer angiogenesis and antiangiogenesis.
[14562004] Br J Cancer 89(8): 1395-9 (2003)
2003  
337
Surrogate markers in antiangiogenesis clinical trials.
[12838293] Br J Cancer 89(1): 8-14 (2003)
2008  
338
Angiogenesis in pre-malignant conditions.
[18941463] Br J Cancer 99(12): 1961-6 (2008)
2003  
339
Angiogenesis assays: a critical overview.
[12507958] Clin Chem 49(1): 32-40 (2003)
2009  
340
Therapeutic angiogenesis in diabetes and hypercholesterolemia: influence of oxidative stress.
[19187003] Antioxid Redox Signal 11(8): 1945-59 (2009)
2009  
341
Redox-dependent mechanisms in coronary collateral growth: the "redox window" hypothesis.
[19416057] Antioxid Redox Signal 11(8): 1961-74 (2009)
2009  
342
Novel role of NADPH oxidase in angiogenesis and stem/progenitor cell function.
[19309262] Antioxid Redox Signal 11(10): 2517-33 (2009)
2005  
343
2008  
344
Antiangiogenic therapy in brain tumors.
[18928341] Expert Rev Neurother 8(10): 1457-73 (2008)
2010  
345
Preclinical molecular imaging of tumor angiogenesis.
[20639815] Q J Nucl Med Mol Imaging 54(3): 291-308 (2010)
2008  
346
Plasma membrane microparticles in angiogenesis: role in ischemic diseases and in cancer.
[18597583] Physiol Res 57(3): 311-20 (2008)
2011  
347
Recent advances in anti-angiogenic therapy of cancer.
[21399234] Oncotarget 2(3): 122-34 (2011)
2010  
348
Targeting tumor angiogenesis with TSP-1-based compounds: rational design of antiangiogenic mimetics of endogenous inhibitors.
[21317461] Oncotarget 1(7): 662-73 (2010)
2010  
349
Antiangiogenic agents in advanced gastrointestinal malignancies: past, present and a novel future.
[21317448] Oncotarget 1(7): 515-29 (2010)
2009  
350
Targeting tumor angiogenesis with histone deacetylase inhibitors.
[19111391] Cancer Lett 280(2): 145-53 (2009)
2008  
351
Reactive oxygen species and angiogenesis: NADPH oxidase as target for cancer therapy.
[18406051] Cancer Lett 266(1): 37-52 (2008)
2009  
352
Molecular regulation of tumor angiogenesis and perfusion via redox signaling.
[19374334] Chem Rev 109(7): 3099-124 (2009)
2009  
353
Integrins as "functional hubs" in the regulation of pathological angiogenesis.
[19482089] Semin Cancer Biol 19(5): 318-28 (2009)
2010  
354
Approaches to multimodality imaging of angiogenesis.
[20457795] J Nucl Med 51 Suppl 1(-): 66S-79S (2010)
2009  
355
Possible novel targets for therapeutic angiogenesis.
[19071062] Curr Opin Pharmacol 9(2): 102-8 (2009)
2009  
356
Helping the circulatory system heal itself: manipulating kinin signaling to promote neovascularization.
[19296754] Expert Rev Cardiovasc Ther 7(3): 215-9 (2009)
2009  
357
Angiogenesis in the kidney: a new therapeutic target?
[19430335] Curr Opin Nephrol Hypertens 18(2): 160-5 (2009)
2010  
358
Antivascular effects of electrochemotherapy: implications in treatment of bleeding metastases.
[20470005] Expert Rev Anticancer Ther 10(5): 729-46 (2010)
2003  
359
Melanoma differentiation-associated gene 7/interleukin (IL)-24 is a novel ligand that regulates angiogenesis via the IL-22 receptor.
[12941841] Cancer Res 63(16): 5105-13 (2003)
2004  
360
Adenovirus-mediated mda-7 (IL24) gene therapy suppresses angiogenesis and sensitizes NSCLC xenograft tumors to radiation.
[15194048] Mol Ther 9(6): 818-28 (2004)
2009  
361
Brain angiogenesis in developmental and pathological processes: mechanism and therapeutic intervention in brain tumors.
[19664069] FEBS J 276(17): 4653-64 (2009)
2011  
362
Orai1 and CRAC channel dependence of VEGF-activated Ca2+ entry and endothelial tube formation.
[21441136] Circ Res 108(10): 1190-8 (2011)
2011  
363
Cerebral arteriogenesis is enhanced by pharmacological as well as fluid-shear-stress activation of the Trpv4 calcium channel.
[21316269] Eur J Vasc Endovasc Surg 41(5): 589-96 (2011)
2009  
364
Trpv4 induces collateral vessel growth during regeneration of the arterial circulation.
[19017361] J Cell Mol Med 13(8B): 2613-21 (2009)
2010  
365
Calcium-dependent signalling is essential during collateral growth in the pig hind limb-ischemia model.
[20363225] J Mol Cell Cardiol 49(1): 142-51 (2010)
2012  
366
TRPV4 mediates tumor-derived endothelial cell migration via arachidonic acid-activated actin remodeling.
[21685934] Oncogene 31(2): 200-12 (2012)
2007  
367
Antiangiogenics: the potential role of integrating this novel treatment modality with chemoradiation for solid cancers.
[17827451] J Clin Oncol 25(26): 4033-42 (2007)
2008  
368
Integrins in angiogenesis and lymphangiogenesis.
[18497750] Nat Rev Cancer 8(8): 604-17 (2008)
2010  
369
Signaling circuitry in vascular morphogenesis.
[20216211] Curr Opin Hematol 17(3): 213-8 (2010)
2008  
370
Fibroblast growth factor regulation of neovascularization.
[18391788] Curr Opin Hematol 15(3): 215-20 (2008)
2010  
371
Angiogenesis inhibitors: current strategies and future prospects.
[20554717] CA Cancer J Clin 60(4): 222-43 (2010)
2008  
372
Foxc2 transcription factor: a newly described regulator of angiogenesis.
[19185813] Trends Cardiovasc Med 18(6): 224-8 (2008)
2007  
373
Brain-derived neurotrophic factor: a newly described mediator of angiogenesis.
[17482097] Trends Cardiovasc Med 17(4): 140-3 (2007)
2007  
374
Rebuilding the coronary vasculature: hedgehog as a new candidate for pharmacologic revascularization.
[17418368] Trends Cardiovasc Med 17(3): 77-83 (2007)
2009  
375
Hypoxia-regulated angiogenic inhibitors.
[20447566] Trends Cardiovasc Med 19(8): 252-6 (2009)
2008  
376
Thrombospondin and apoptosis: molecular mechanisms and use for design of complementation treatments.
[18855619] Curr Drug Targets 9(10): 851-62 (2008)
2003  
377
Regulation by prostaglandin E2 and histamine of angiogenesis in inflammatory granulation tissue.
[12772586] Yakugaku Zasshi 123(5): 295-303 (2003)
2010  
378
Endothelial colony-forming cell role in neoangiogenesis and tissue repair.
[19898235] Curr Opin Organ Transplant 15(1): 68-72 (2010)
2011  
379
Tumor Vessel Development and Expansion in Ewing's Sarcoma: A Review of the Vasculogenesis Process and Clinical Trials with Vascular-Targeting Agents.
[21785569] Sarcoma 2011(-): 165837 (2011)
2011  
380
Targeting angiogenesis in childhood sarcomas.
[21197468] Sarcoma 2011(-): 601514 (2011)
2007  
381
Effects of antiretroviral therapy on tube-like network formation of human endothelial cells.
[17473447] Biol Pharm Bull 30(5): 982-4 (2007)
2010  
382
Specification of arterial, venous, and lymphatic endothelial cells during embryonic development.
[20238301] Histol Histopathol 25(5): 637-46 (2010)
2010  
383
Role of endothelial progenitor cells during ischemia-induced vasculogenesis and collateral formation.
[20144623] Microvasc Res 79(3): 200-6 (2010)
2008  
384
Computational and mathematical modeling of angiogenesis.
[18720228] Microcirculation 15(8): 739-51 (2008)
2002  
385
Angiogenesis in health and disease: insights into basic mechanisms and therapeutic opportunities.
[12214844] J Dent Educ 66(8): 962-75 (2002)
2008  
386
Roles of integrins in tumor angiogenesis and lymphangiogenesis.
[19093788] Lymphat Res Biol 6(3-4): 155-63 (2008)
2009  
387
2007  
388
Angiogenesis and vasculogenesis: inducing the growth of new blood vessels and wound healing by stimulation of bone marrow-derived progenitor cell mobilization and homing.
[17544023] J Vasc Surg 45 Suppl A(-): A39-47 (2007)
2009  
389
Biomarkers of response and resistance to antiangiogenic therapy.
[19483739] Nat Rev Clin Oncol 6(6): 327-38 (2009)
2010  
390
New insights in synovial angiogenesis.
[20022538] Joint Bone Spine 77(1): 13-9 (2010)
2010  
391
Collateral damage: toxic effects of targeted antiangiogenic therapies in ovarian cancer.
[20226736] Lancet Oncol 11(5): 465-75 (2010)
2005  
392
Anti-angiogenic and anti-inflammatory effects of statins: relevance to anti-cancer therapy.
[16375664] Curr Cancer Drug Targets 5(8): 579-94 (2005)
2010  
393
EGFL7 meets miRNA-126: an angiogenesis alliance.
[20529320] J Angiogenes Res 2(1): 9 (2010)
2009  
394
Controlling the angiogenic switch in developing atherosclerotic plaques: possible targets for therapeutic intervention.
[19946412] J Angiogenes Res 1(-): 4 (2009)
2010  
395
Molecular mediators of angiogenesis.
[20061852] J Burn Care Res 31(1): 158-75 (2010)
2010  
396
The mouse retina as an angiogenesis model.
[20484600] Invest Ophthalmol Vis Sci 51(6): 2813-26 (2010)
2008  
397
New molecular targets in angiogenic vessels of glioblastoma tumours.
[18684337] Expert Rev Mol Med 10(-): e23 (2008)
2007  
398
Tumour vascularization: sprouting angiogenesis and beyond.
[17717633] Cancer Metastasis Rev 26(3-4): 489-502 (2007)
2008  
399
The tumor microenvironment: regulation by MMP-independent effects of tissue inhibitor of metalloproteinases-2.
[18058195] Cancer Metastasis Rev 27(1): 57-66 (2008)
2008  
400
Clinical biomarkers of angiogenesis inhibition.
[18414993] Cancer Metastasis Rev 27(3): 415-34 (2008)
2008  
401
Targeting vasculature in urologic tumors: mechanistic and therapeutic significance.
[17668426] J Cell Biochem 103(3): 691-708 (2008)
2010  
402
The Norrin/Frizzled4 signaling pathway in retinal vascular development and disease.
[20688566] Trends Mol Med 16(9): 417-25 (2010)
2011  
403
Galectin-1-mediated biochemical controls of melanoma and glioma aggressive behavior.
[21949569] World J Biol Chem 2(9): 193-201 (2011)
2010  
404
Sphingosine-1-phosphate signaling in vasculogenesis and angiogenesis.
[21537462] World J Biol Chem 1(10): 291-7 (2010)
2008  
405
Matrix metalloproteinase control of capillary morphogenesis.
[18540825] Crit Rev Eukaryot Gene Expr 18(3): 251-78 (2008)
2011  
406
Rat mesentery angiogenesis assay.
[21712799] J Vis Exp -(52): - (2011)
2009  
407
Notch signalling in ischaemia-induced angiogenesis.
[19909251] Biochem Soc Trans 37(Pt 6): 1221-7 (2009)
2011  
408
The roles of microRNAs in tumorigenesis and angiogenesis.
[21760972] Int J Physiol Pathophysiol Pharmacol 3(2): 140-55 (2011)
2010  
409
Mast cells and basophils: a potential link in promoting angiogenesis during allergic inflammation.
[19752562] Int Arch Allergy Immunol 151(2): 89-97 (2010)
2008  
410
Anti-angiogenesis: making the tumor vulnerable to the immune system.
[18438662] Cancer Immunol Immunother 57(10): 1553-8 (2008)
2008  
411
Multicellular sprouting during vasculogenesis.
[18023731] Curr Top Dev Biol 81(-): 269-89 (2008)
2009  
412
Transcriptional control of endothelial cell development.
[19217421] Dev Cell 16(2): 180-95 (2009)
2011  
413
Nanotechnology-mediated targeting of tumor angiogenesis.
[21349160] Vasc Cell 3(1): 3 (2011)
2011  
414
Vaccines targeting the neovasculature of tumors.
[21385454] Vasc Cell 3(1): 7 (2011)
2011  
415
Nanoparticle mediated targeting of VEGFR and cancer stem cells for cancer therapy.
[22082307] Vasc Cell 3(-): 26 (2011)
2011  
416
Dll4-Notch signaling as a therapeutic target in tumor angiogenesis.
[21923938] Vasc Cell 3(1): 20 (2011)
2009  
417
Angiogenesis in rheumatoid arthritis.
[19863375] Autoimmunity 42(7): 563-73 (2009)
2011  
418
Anti-angiogenic peptides for cancer therapeutics.
[21470139] Curr Pharm Biotechnol 12(8): 1101-16 (2011)
2010  
419
Systems biology of pro-angiogenic therapies targeting the VEGF system.
[20890966] Wiley Interdiscip Rev Syst Biol Med 2(6): 694-707 (2010)
PMC   
420
Vascular endothelial growth factor signaling regulates the segregation of artery and vein via ERK activity during vascular development.
[23266606] Biochem Biophys Res Commun 430(4):1212-6 (2013)
PMC   
421
Lipid phosphate phosphatase (LPP3) and vascular development.
[22835522] Biochim Biophys Acta 1831(1):126-32 (2013)
PMC   
422
S1P1 bridges mechanotransduction and angiogenesis during vascular development.
[22975318] Dev Cell 23(3):451-2 (2012)
PMC   
423
Nerve control of blood vessel patterning.
[23449469] Dev Cell 24(4):340-1 (2013)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.



  • Angiogenese

  • The BDOM Bibliographic Dictionary of Medicine is a curated collection of free medical articles tagged to concepts.
    Contents until 2011 are reviews from PubMed, contents flagged 'PMC' are regular articles from PubMed Central.
    Search BDOM
    Nephrology Collection
    Radiology Locator

    PubMedCentral monthly collection of free medical articles by major subject

    The framed wikipedia articles are from en.wikipedia.org and they are the actual versions; the first is from Nephropedia